CDC Grand Rounds: Getting Smart About Antibiotics
Each year in the United States, approximately two million persons become infected with antibiotic-resistant bacteria, at least 23,000 persons die as a direct result of these infections, and many more die from conditions complicated by a resistant infection. Antibiotic-resistant infections contribute...
Gespeichert in:
| Veröffentlicht in: | MMWR. Morbidity and mortality weekly report 2015-08, Vol.64 (32), p.871-873 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 873 |
|---|---|
| container_issue | 32 |
| container_start_page | 871 |
| container_title | MMWR. Morbidity and mortality weekly report |
| container_volume | 64 |
| creator | Demirjian, Alicia Sanchez, Guillermo V. Finkelstein, Jonathan A. Ling, Shari M. Srinivasan, Arjun Pollack, Lori A. Hicks, Lauri A. Iskander, John K. |
| description | Each year in the United States, approximately two million persons become infected with antibiotic-resistant bacteria, at least 23,000 persons die as a direct result of these infections, and many more die from conditions complicated by a resistant infection. Antibiotic-resistant infections contribute to poor health outcomes, higher health care costs, and use of more toxic treatments. Although emerging resistance mechanisms are being identified and resistant infections are on the rise, new antibiotic development has slowed considerably. |
| doi_str_mv | 10.15585/mmwr.mm6432a3 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5779583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A426901112</galeid><jstor_id>24856663</jstor_id><sourcerecordid>A426901112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-9fc1c4e3b2d3e13acadf41fd062b4bd4f17afc010c173b2a3a0a764e981abd993</originalsourceid><addsrcrecordid>eNptkVtLwzAYhoMoOg_glXfKQPCuM19ObW6EUY8wEETBu5CmyVZpGmk6xX9v5zwNlptAvud94MuL0BHgEXCe8XPv39uR94JRoukGGgBnPMkEPG-iAQYmEwKS76DdGF_w4lC8jXaIIJIQzAfoML_MhzetbsrhQ5g3ZdxHW07X0R5833vo6frqMb9NJvc3d_l4khjOsi6RzoBhlhakpBaoNrp0DFyJBSlYUTIHqXYGAzaQ9pCmGutUMCsz0EUpJd1DF0vv67zwtjS26Vpdq9e28rr9UEFXanXSVDM1DW-Kp6nkGe0Fp0vBVNdWVY0LPWZ8FY0aMyIkBgDSU8kaamob2ztDY13VP6_wozX8Yj3rK7M2cPYvMLO67mYx1POuCk1cazZtiLG17ndXwOqrS7XoUv102QdO_v_QL_5TXg8cL4GX2IX2b84yLoSg9BOVZKJC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CDC Grand Rounds: Getting Smart About Antibiotics</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><creator>Demirjian, Alicia ; Sanchez, Guillermo V. ; Finkelstein, Jonathan A. ; Ling, Shari M. ; Srinivasan, Arjun ; Pollack, Lori A. ; Hicks, Lauri A. ; Iskander, John K.</creator><creatorcontrib>Demirjian, Alicia ; Sanchez, Guillermo V. ; Finkelstein, Jonathan A. ; Ling, Shari M. ; Srinivasan, Arjun ; Pollack, Lori A. ; Hicks, Lauri A. ; Iskander, John K.</creatorcontrib><description>Each year in the United States, approximately two million persons become infected with antibiotic-resistant bacteria, at least 23,000 persons die as a direct result of these infections, and many more die from conditions complicated by a resistant infection. Antibiotic-resistant infections contribute to poor health outcomes, higher health care costs, and use of more toxic treatments. Although emerging resistance mechanisms are being identified and resistant infections are on the rise, new antibiotic development has slowed considerably.</description><identifier>ISSN: 0149-2195</identifier><identifier>EISSN: 1545-861X</identifier><identifier>DOI: 10.15585/mmwr.mm6432a3</identifier><identifier>PMID: 26292205</identifier><language>eng</language><publisher>United States: Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Centers for Disease Control and Prevention, U.S ; Clinical Competence ; Drug Resistance, Bacterial ; Forecasting ; Health care costs ; Humans ; Practice Guidelines as Topic ; Practice Patterns, Physicians' - standards ; United States</subject><ispartof>MMWR. Morbidity and mortality weekly report, 2015-08, Vol.64 (32), p.871-873</ispartof><rights>COPYRIGHT 2015 U.S. Government Printing Office</rights><rights>2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-9fc1c4e3b2d3e13acadf41fd062b4bd4f17afc010c173b2a3a0a764e981abd993</citedby><cites>FETCH-LOGICAL-c548t-9fc1c4e3b2d3e13acadf41fd062b4bd4f17afc010c173b2a3a0a764e981abd993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/24856663$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/24856663$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,725,778,782,801,883,27907,27908,53774,53776,58000,58233</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26292205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demirjian, Alicia</creatorcontrib><creatorcontrib>Sanchez, Guillermo V.</creatorcontrib><creatorcontrib>Finkelstein, Jonathan A.</creatorcontrib><creatorcontrib>Ling, Shari M.</creatorcontrib><creatorcontrib>Srinivasan, Arjun</creatorcontrib><creatorcontrib>Pollack, Lori A.</creatorcontrib><creatorcontrib>Hicks, Lauri A.</creatorcontrib><creatorcontrib>Iskander, John K.</creatorcontrib><title>CDC Grand Rounds: Getting Smart About Antibiotics</title><title>MMWR. Morbidity and mortality weekly report</title><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><description>Each year in the United States, approximately two million persons become infected with antibiotic-resistant bacteria, at least 23,000 persons die as a direct result of these infections, and many more die from conditions complicated by a resistant infection. Antibiotic-resistant infections contribute to poor health outcomes, higher health care costs, and use of more toxic treatments. Although emerging resistance mechanisms are being identified and resistant infections are on the rise, new antibiotic development has slowed considerably.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Centers for Disease Control and Prevention, U.S</subject><subject>Clinical Competence</subject><subject>Drug Resistance, Bacterial</subject><subject>Forecasting</subject><subject>Health care costs</subject><subject>Humans</subject><subject>Practice Guidelines as Topic</subject><subject>Practice Patterns, Physicians' - standards</subject><subject>United States</subject><issn>0149-2195</issn><issn>1545-861X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkVtLwzAYhoMoOg_glXfKQPCuM19ObW6EUY8wEETBu5CmyVZpGmk6xX9v5zwNlptAvud94MuL0BHgEXCe8XPv39uR94JRoukGGgBnPMkEPG-iAQYmEwKS76DdGF_w4lC8jXaIIJIQzAfoML_MhzetbsrhQ5g3ZdxHW07X0R5833vo6frqMb9NJvc3d_l4khjOsi6RzoBhlhakpBaoNrp0DFyJBSlYUTIHqXYGAzaQ9pCmGutUMCsz0EUpJd1DF0vv67zwtjS26Vpdq9e28rr9UEFXanXSVDM1DW-Kp6nkGe0Fp0vBVNdWVY0LPWZ8FY0aMyIkBgDSU8kaamob2ztDY13VP6_wozX8Yj3rK7M2cPYvMLO67mYx1POuCk1cazZtiLG17ndXwOqrS7XoUv102QdO_v_QL_5TXg8cL4GX2IX2b84yLoSg9BOVZKJC</recordid><startdate>20150821</startdate><enddate>20150821</enddate><creator>Demirjian, Alicia</creator><creator>Sanchez, Guillermo V.</creator><creator>Finkelstein, Jonathan A.</creator><creator>Ling, Shari M.</creator><creator>Srinivasan, Arjun</creator><creator>Pollack, Lori A.</creator><creator>Hicks, Lauri A.</creator><creator>Iskander, John K.</creator><general>Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</general><general>U.S. Government Printing Office</general><general>U.S. Centers for Disease Control</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20150821</creationdate><title>CDC Grand Rounds</title><author>Demirjian, Alicia ; Sanchez, Guillermo V. ; Finkelstein, Jonathan A. ; Ling, Shari M. ; Srinivasan, Arjun ; Pollack, Lori A. ; Hicks, Lauri A. ; Iskander, John K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-9fc1c4e3b2d3e13acadf41fd062b4bd4f17afc010c173b2a3a0a764e981abd993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Centers for Disease Control and Prevention, U.S</topic><topic>Clinical Competence</topic><topic>Drug Resistance, Bacterial</topic><topic>Forecasting</topic><topic>Health care costs</topic><topic>Humans</topic><topic>Practice Guidelines as Topic</topic><topic>Practice Patterns, Physicians' - standards</topic><topic>United States</topic><toplevel>online_resources</toplevel><creatorcontrib>Demirjian, Alicia</creatorcontrib><creatorcontrib>Sanchez, Guillermo V.</creatorcontrib><creatorcontrib>Finkelstein, Jonathan A.</creatorcontrib><creatorcontrib>Ling, Shari M.</creatorcontrib><creatorcontrib>Srinivasan, Arjun</creatorcontrib><creatorcontrib>Pollack, Lori A.</creatorcontrib><creatorcontrib>Hicks, Lauri A.</creatorcontrib><creatorcontrib>Iskander, John K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MMWR. Morbidity and mortality weekly report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demirjian, Alicia</au><au>Sanchez, Guillermo V.</au><au>Finkelstein, Jonathan A.</au><au>Ling, Shari M.</au><au>Srinivasan, Arjun</au><au>Pollack, Lori A.</au><au>Hicks, Lauri A.</au><au>Iskander, John K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CDC Grand Rounds: Getting Smart About Antibiotics</atitle><jtitle>MMWR. Morbidity and mortality weekly report</jtitle><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><date>2015-08-21</date><risdate>2015</risdate><volume>64</volume><issue>32</issue><spage>871</spage><epage>873</epage><pages>871-873</pages><issn>0149-2195</issn><eissn>1545-861X</eissn><abstract>Each year in the United States, approximately two million persons become infected with antibiotic-resistant bacteria, at least 23,000 persons die as a direct result of these infections, and many more die from conditions complicated by a resistant infection. Antibiotic-resistant infections contribute to poor health outcomes, higher health care costs, and use of more toxic treatments. Although emerging resistance mechanisms are being identified and resistant infections are on the rise, new antibiotic development has slowed considerably.</abstract><cop>United States</cop><pub>Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</pub><pmid>26292205</pmid><doi>10.15585/mmwr.mm6432a3</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-2195 |
| ispartof | MMWR. Morbidity and mortality weekly report, 2015-08, Vol.64 (32), p.871-873 |
| issn | 0149-2195 1545-861X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5779583 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Jstor Complete Legacy; PubMed Central |
| subjects | Anti-Bacterial Agents - therapeutic use Antibiotics Centers for Disease Control and Prevention, U.S Clinical Competence Drug Resistance, Bacterial Forecasting Health care costs Humans Practice Guidelines as Topic Practice Patterns, Physicians' - standards United States |
| title | CDC Grand Rounds: Getting Smart About Antibiotics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T12%3A21%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CDC%20Grand%20Rounds:%20Getting%20Smart%20About%20Antibiotics&rft.jtitle=MMWR.%20Morbidity%20and%20mortality%20weekly%20report&rft.au=Demirjian,%20Alicia&rft.date=2015-08-21&rft.volume=64&rft.issue=32&rft.spage=871&rft.epage=873&rft.pages=871-873&rft.issn=0149-2195&rft.eissn=1545-861X&rft_id=info:doi/10.15585/mmwr.mm6432a3&rft_dat=%3Cgale_pubme%3EA426901112%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26292205&rft_galeid=A426901112&rft_jstor_id=24856663&rfr_iscdi=true |